Barclays PLC lifted its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 323.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,703 shares of the real estate investment trust's stock after acquiring an additional 54,782 shares during the quarter. Barclays PLC owned approximately 0.16% of National Health Investors worth $6,027,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently made changes to their positions in NHI. Charles Schwab Investment Management Inc. boosted its position in National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after acquiring an additional 123,596 shares during the last quarter. Land & Buildings Investment Management LLC lifted its stake in shares of National Health Investors by 4.6% in the 2nd quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust's stock valued at $28,300,000 after purchasing an additional 18,232 shares during the period. Zimmer Partners LP bought a new stake in shares of National Health Investors during the 3rd quarter valued at about $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock worth $20,370,000 after purchasing an additional 186,238 shares during the period. Finally, Sound Income Strategies LLC increased its holdings in National Health Investors by 10.8% in the third quarter. Sound Income Strategies LLC now owns 169,582 shares of the real estate investment trust's stock worth $14,255,000 after purchasing an additional 16,463 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have issued reports on NHI shares. Bank of America began coverage on National Health Investors in a report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price target on the stock. StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Truist Financial lifted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research note on Friday, August 30th. Finally, Wells Fargo & Company cut shares of National Health Investors from an "overweight" rating to an "equal weight" rating and increased their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $76.33.
Get Our Latest Stock Report on National Health Investors
National Health Investors Stock Up 1.5 %
NHI traded up $1.01 during trading on Friday, hitting $69.85. 750,877 shares of the company's stock were exchanged, compared to its average volume of 204,402. The stock has a market cap of $3.17 billion, a P/E ratio of 24.00, a PEG ratio of 4.86 and a beta of 1.04. The business's 50 day moving average is $76.18 and its two-hundred day moving average is $75.52. National Health Investors, Inc. has a fifty-two week low of $51.59 and a fifty-two week high of $86.13. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company's revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.08 EPS. As a group, equities analysts expect that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 5.15%. National Health Investors's dividend payout ratio (DPR) is currently 123.71%.
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.